ANI Announces Launch of Authorized Generic of Brethine(R)

BAUDETTE, Minn., Oct. 16, 2018 -- (Healthcare Sales & Marketing Network) -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Terbutaline Sulfate Tablets USP, 2.5mg and 5mg, an authorized generic of Brethine®. Th... Biopharmaceuticals, Generics, Product Launch ANI Pharmaceuticals, Terbutaline, Brethine, bronchitis, emphysema
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news